Abstract
Glycoproteins are essential in the production, transport, storage and regulation of thyroid hormones. Altered glycosylation has a potential impact on thyroid function. Abnormal thyroid function tests have been described in patients with congenital disorders of glycosylation. We evaluated the reliability of biochemical markers and investigated thyroid function in 18 PMM2-CDG patients. We propose an expectative therapeutic approach for neonates with thyroid abnormalities in CDG.
Copyright © 2012 Elsevier Inc. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Adult
-
Child
-
Child, Preschool
-
Congenital Disorders of Glycosylation / diagnosis*
-
Congenital Disorders of Glycosylation / enzymology
-
Congenital Disorders of Glycosylation / therapy*
-
Female
-
Follow-Up Studies
-
Glycosylation
-
Humans
-
Infant
-
Infant, Newborn
-
Longitudinal Studies
-
Male
-
Neuraminidase / pharmacology*
-
Phosphotransferases (Phosphomutases) / metabolism*
-
Retrospective Studies
-
Thyroid Function Tests
-
Thyrotropin / metabolism
-
Young Adult
Substances
-
Thyrotropin
-
Neuraminidase
-
Phosphotransferases (Phosphomutases)
-
phosphomannomutase 2, human